The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Gout: An old disease in new perspective – A review
Open accessAbstract
Gout is a picturesque presentation of uric acid disturbance. It is the most well understood and described type of arthritis. Its epidemiology is studied. New insights into the pathophysiology of hyperuricemia and gouty arthritis; acute and chronic allow for an even better understanding of the disease. The role of genetic predisposition is becoming more evident. The clinical picture of gout is divided into asymptomatic hyperuricemia, acute gouty arthritis, intercritical period, and chronic tophaceous gout. Diagnosis is based on laboratory and radiological features. The gold standard of diagnosis is identification of characteristic MSU crystals in the synovial fluid using polarized light microscopy. Imaging modalities include conventional radiography, ultrasonography, conventional CT, Dual-Energy CT, Magnetic Resonance Imaging, nuclear scintigraphy, and positron emission tomography. There is remarkable progress in the application of ultrasonography and Dual-Energy CT which is bound to influence the diagnosis, staging, follow-up, and clinical research in the field. Management of gout includes management of flares, chronic gout and prevention of flares, as well as management of comorbidities. Newer drugs in the pharmacological armamentarium are proving successful and supplement older ones. Other important points in its management include patient education, diet and life style changes, as well as cessation of hyperuricemic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bastuji‐Garin, S. (1993) · Archives of Dermatology · doi:10.1001/archderm.129.1.92 · Cited by 1,697
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Self-citationKhanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature
Casagranda, A., Suppa, M., Dehavay, F., & del Marmol, V. (2017) · Case Reports in Dermatology · doi:10.1159/000475802 · Cited by 1,466
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Self-citationFebuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284
Global epidemiology of gout: prevalence, incidence and risk factors
Kuo, C.-F., Grainge, M. J., Zhang, W., & Doherty, M. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.91 · Cited by 1,179
Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00346-9 · Cited by 1,087
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A., & Thompson, P. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.027 · Cited by 1,054
Kardaun, S. H., Sidoroff, A., Valeyrie-Allanore, L., Halevy, S., Davidovici, B. B., Mockenhaupt, M., & Roujeau, J. C. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07704.x · Cited by 934
Acute generalized exanthematous pustulosis (AGEP) – A clinical reaction pattern
Sidoroff, A., Halevy, S., Bavinck, J. N. B., Vaillant, L., & Roujeau, J. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.028003113.x · Cited by 818
Khanna, D., Khanna, P. P., Fitzgerald, J. D., Singh, M. K., Bae, S., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21773 · Cited by 728
A pilot study of IL-1 inhibition by anakinra in acute gout
So, A., De Smedt, T., Revaz, S., & Tschopp, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2143 · Cited by 727
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Ichida, K., Matsuo, H., Takada, T., Nakayama, A., Murakami, K., Shimizu, T., Yamanashi, Y., Kasuga, H., Nakashima, H., Nakamura, T., et al. (2012) · Nature Communications · doi:10.1038/ncomms1756 · Cited by 701
Hande, K. R., Noone, R. M., & Stone, W. J. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90743-5 · Cited by 680
Kolz, M., Johnson, T., Sanna, S., Teumer, A., Vitart, V., Perola, M., Mangino, M., Albrecht, E., Wallace, C., Farrall, M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000504 · Cited by 658
Schumacher, H. R., Becker, M. A., Wortmann, R. L., MacDonald, P. A., Hunt, B., Streit, J., Lademacher, C., & Joseph‐Ridge, N. (2008) · Arthritis Care & Research · doi:10.1002/art.24209 · Cited by 638 · cited 1×
“At the doses of 80 and 120 mg/d, the maximum doses approved in the USA and Europe respectively, febuxostat is a more potent ULD than allopurinol 300 mg/d [144,145].”
BackgroundVallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635 · cited 1×
“The recently introduced SGLT2 inhibitors also have interesting urate lowering effects [179].”
BackgroundZhang, W., Doherty, M., Pascual, E., Bardin, T., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055251 · Cited by 584
Self-citationThe Molecular Physiology of Uric Acid Homeostasis
Mandal, A. K., & Mount, D. B. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170343 · Cited by 550
American College of Rheumatology guidelines for management of gout
Khanna, D. (2013) · GOUT AND NUCLEIC ACID METABOLISM · doi:10.6032/gnam.37.139 · Cited by 539
Terkeltaub, R. A., Furst, D. E., Bennett, K., Kook, K. A., Crockett, R. S., & Davis, M. W. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27327 · Cited by 536
Azadbakht, L., Mirmiran, P., Esmaillzadeh, A., Azizi, T., & Azizi, F. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2823 · Cited by 536
Emmerson, B. T. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340707 · Cited by 516
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Annemans, L., Spaepen, E., Gaskin, M., Bonnemaire, M., Malier, V, Gilbert, T., & Nuki, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076232 · Cited by 495
IDENTIFICATION OF URATE CRYSTALS IN GOUTY SYNOVIAL FLUID
MCCARTY, D. J., & HOLLANDER, J. L. (1961) · Annals of Internal Medicine · doi:10.7326/0003-4819-54-3-452 · Cited by 486
Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout
Perez‐Ruiz, F., Calabozo, M., Pijoan, J. I., Herrero‐Beites, A. M., & Ruibal, A. (2002) · Arthritis Care & Research · doi:10.1002/art.10511 · Cited by 454
Colchicine Myopathy and Neuropathy
Kuncl, R. W., Duncan, G., Watson, D., Alderson, K., Rogawski, M. A., & Peper, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706183162502 · Cited by 427
Mechanism of Action of Colchicine in the Treatment of Gout
Dalbeth, N., Lauterio, T. J., & Wolfe, H. R. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.017 · Cited by 416
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
Bobulescu, I. A., & Moe, O. W. (2012) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2012.07.009 · Cited by 402
Schlesinger, N., Alten, R. E., Bardin, T., Schumacher, H. R., Bloch, M., Gimona, A., Krammer, G., Murphy, V., Richard, D., & So, A. K. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200908 · Cited by 359
Self-citationDiagnosis of gout by ultrasound
Thiele, R. G., & Schlesinger, N. (2007) · Rheumatology · doi:10.1093/rheumatology/kem058 · Cited by 348
Qaseem, A., Harris, R. P., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m16-0570 · Cited by 341
Dessein, P. H., Shipton, E. A., Stanwix, A. E., Joffe, B. I., & Ramokgadi, J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.7.539 · Cited by 335
Janssens, H. J., Janssen, M., van de Lisdonk, E. H., van Riel, P. L., & van Weel, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60799-0 · Cited by 317
Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome
Torres, R. J., & Puig, J. G. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-48 · Cited by 307
Stamp, L. K., Taylor, W. J., Jones, P. B., Dockerty, J. L., Drake, J., Frampton, C., & Dalbeth, N. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34488 · Cited by 296
Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study
Bongartz, T., Glazebrook, K. N., Kavros, S. J., Murthy, N. S., Merry, S. P., Franz, W. B., Michet, C. J., Veetil, B. M. A., Davis, J. M., Mason, T. G., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205095 · Cited by 276
Rees, F., Jenkins, W., & Doherty, M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201676 · Cited by 272
Gout: why is this curable disease so seldom cured?
Doherty, M., Jansen, T. L., Nuki, G., Pascual, E., Perez-Ruiz, F., Punzi, L., So, A. K., & Bardin, T. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201687 · Cited by 271
Self-citationOccurrence of tendon pathologies in metabolic disorders
Abate, M., Schiavone, C., Salini, V., & Andia, I. (2013) · Rheumatology · doi:10.1093/rheumatology/kes395 · Cited by 270
Perez-Ruiz, F., Alonso-Ruiz, A., Calabozo, M., Herrero-Beites, A., García-Erauskin, G., & Ruiz-Lucea, E. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.9.545 · Cited by 257
Kramer, H. M., & Curhan, G. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33911 · Cited by 253
Kanbay, M., Huddam, B., Azak, A., Solak, Y., Kadioglu, G. K., Kirbas, I., Duranay, M., Covic, A., & Johnson, R. J. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11451210 · Cited by 248
Synovial Fluid Analysis for Diagnosis of Intercritical Gout
Pascual, E., Batlle-Gualda, E., Martínez, A., Rosas, J., & Vela, P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-10-199911160-00007 · Cited by 248
Glazebrook, K. N., Guimarães, L. S., Murthy, N. S., Black, D. F., Bongartz, T., J. Manek, N., Leng, S., Fletcher, J. G., & McCollough, C. H. (2011) · Radiology · doi:10.1148/radiol.11102485 · Cited by 242
Stamp, L. K., O'Donnell, J. L., Zhang, M., James, J., Frampton, C., Barclay, M. L., & Chapman, P. T. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30119 · Cited by 233
Improving cardiovascular and renal outcomes in gout: what should we target?
Richette, P., Perez-Ruiz, F., Doherty, M., Jansen, T. L., Nuki, G., Pascual, E., Punzi, L., So, A. K., & Bardin, T. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.124 · Cited by 229
Self-citationTerkeltaub, R. A., Furst, D. E., DiGiacinto, J. L., Kook, K. A., & Davis, M. W. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30389 · Cited by 228
High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study
Wright, S. A., Filippucci, E., McVeigh, C., Grey, A., McCarron, M., Grassi, W., Wright, G. D., & Taggart, A. J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062802 · Cited by 228
Dalbeth, N., Kumar, S., Stamp, L. K., & Gow, P. J. (2006) · PubMed · Cited by 226
Ko, T.-M., Tsai, C.-Y., Chen, S.-Y., Chen, K.-S., Yu, K.-H., Chu, C.-S., Huang, C.-M., Wang, C.-R., Weng, C.-T., Yu, C.-L., et al. (2015) · BMJ · doi:10.1136/bmj.h4848 · Cited by 209
Dalbeth, N., Clark, B., Gregory, K., Gamble, G., Sheehan, T., Doyle, A., & McQueen, F. M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094201 · Cited by 205
Gerster, J. C., Landry, M., Dufresne, L., & Meuwly, J. Y. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.1.52 · Cited by 201
Chung, W.-H., Chang, W.-C., Stocker, S. L., Juo, C.-G., Graham, G. G., Lee, M.-H. H., Williams, K. M., Tian, Y.-C., Juan, K.-C., Jan Wu, Y.-J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205577 · Cited by 195
Medication Adherence in Gout: A Systematic Review
De Vera, M. A., Marcotte, G., Rai, S., Galo, J. S., & Bhole, V. (2014) · Arthritis Care & Research · doi:10.1002/acr.22336 · Cited by 184
Saag, K. G., Fitz‐Patrick, D., Kopicko, J., Fung, M., Bhakta, N., Adler, S., Storgard, C., Baumgartner, S., & Becker, M. A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39840 · Cited by 184
Enomoto, A., & Endou, H. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0368-5 · Cited by 181
Yang, C.-Y., Chen, C.-H., Deng, S.-T., Huang, C.-S., Lin, Y.-J., Chen, Y.-J., Wu, C.-Y., Hung, S.-I., & Chung, W.-H. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.3536 · Cited by 180
Naredo, E., Uson, J., Jiménez-Palop, M., Martínez, A., Vicente, E., Brito, E., Rodríguez, A., Cornejo, F. J., Castañeda, S., Martínez, M. J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203487 · Cited by 180
Man, C. Y., Cheung, I. T. F., Cameron, P. A., & Rainer, T. H. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.11.014 · Cited by 177
Bardin, T., Keenan, R. T., Khanna, P. P., Kopicko, J., Fung, M., Bhakta, N., Adler, S., Storgard, C., Baumgartner, S., & So, A. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209213 · Cited by 169
Self-citationThe pathogenesis of bone erosions in gouty arthritis
Schlesinger, N., & Thiele, R. G. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.128454 · Cited by 166
Urinary Xanthine Stones-a Rare Complication of Allopurinol Therapy
Greene, M. L., Fujimoto, W. Y., & Seegmiller, J. E. (1969) · New England Journal of Medicine · doi:10.1056/nejm196902202800806 · Cited by 165
Pascual, E., & Sivera, F. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.060368 · Cited by 163
Reinders, M. K., van Roon, E. N., Jansen, T. L. T. A., Delsing, J., Griep, E. N., Hoekstra, M., van de Laar, M. A. F. J., & Brouwers, J. R. B. J. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083071 · Cited by 162
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
Cronstein, B. N., & Sunkureddi, P. R. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31827d8790 · Cited by 160
Chhana, A., & Dalbeth, N. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-014-0492-x · Cited by 160
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia
Milionis, H. J., Kakafika, A. I., Tsouli, S. G., Athyros, V. G., Bairaktari, E. T., Seferiadis, K. I., & Elisaf, M. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.005 · Cited by 159
Twenty-eight loci that influence serum urate levels: analysis of association with gout
Phipps‐Green, A. J., Merriman, M. E., Topless, R., Altaf, S., Montgomery, G. W., Franklin, C., Jones, G. T., van Rij, A., White, D., Stamp, L. K., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205877 · Cited by 155
Clinical Diagnostic Criteria for Gout
Malik, A., Schumacher, H. R., Dinnella, J. E., & Clayburne, G. M. (2009) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e3181945b79 · Cited by 154
Asymptomatic hyperuricemia: to treat or not to treat.
Dincer, H. E., Dincer, A. P., & Levinson, D. J. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.8.594 · Cited by 148
Treat-to-target (T2T) recommendations for gout
Kiltz, U., Smolen, J. S., Bardin, T., Solal, A. C., Dalbeth, N., Doherty, M., Engel, B., Flader, C., Kay, J., Matsuoka, M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209467 · Cited by 146
Self-citationPérez-Ruiz, F., Calabozo, M., Fernandez-Lopez, M. J., Herrero-Beites, A. M., Ruiz-Lucea, E., Erauzkin, G. G., Duruelo, J., & Alonso-Ruiz, A. (1999) · JCR Journal of Clinical Rheumatology · doi:10.1097/00124743-199904000-00003 · Cited by 142
Uric Acid and Hypertension: Cause or Effect?
Mazzali, M., Kanbay, M., Segal, M. S., Shafiu, M., Jalal, D. I., Feig, D. I., & Johnson, R. J. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-010-0094-1 · Cited by 142
Hyperlipidaemia in hyperuricaemia and gout
Emmerson, B. T. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.9.509 · Cited by 137
Diagnosis and management of gout
Underwood, M. R. (2006) · BMJ · doi:10.1136/bmj.332.7553.1315 · Cited by 133
Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial
Dalbeth, N., Wong, S., Gamble, G. D., Horne, A. M., Mason, B., Pool, B., Fairbanks, L., McQueen, F. M., Cornish, J., Reid, I. R., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.124230 · Cited by 133
Carpal Tunnel Syndrome Caused by Tophaceous Gout
Chen, C. K., Chung, C. B., Yeh, L., Pan, H., Yang, C., Lai, P., Liang, H., & RESNICK, D. L. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.175.3.1750655 · Cited by 122
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
Ottaviani, S., Moltó, A., Ea, H., Neveu, S., Gill, G., Brunier, L., Palazzo, É., Meyer, O., Richette, P., Bardin, T., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4303 · Cited by 116
Self-citationLiu, R., O'Connell, M. A., Johnson, K., Pritzker, K. P. H., Mackman, N., & Terkeltaub, R. A. (2000) · Arthritis & Rheumatism · Cited by 113
Zhu, Y., Zhang, Y., & Choi, H. K. (2010) · Rheumatology · doi:10.1093/rheumatology/keq256 · Cited by 112
An open-label, 6-month study of allopurinol safety in gout: The LASSO study
Becker, M. A., Fitzpatrick, D., Choi, H. K., Dalbeth, N., Storgard, C. M., Cravets, M., & Baumgartner, S. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.05.005 · Cited by 112
Leptin Might be a Regulator of Serum Uric Acid Concentrations in Humans
Bedir, A., Topbaş, M., Tanyeri, F., Alvur, M., & Arik, I. A. I. N. (2003) · Japanese Heart Journal · doi:10.1536/jhj.44.527 · Cited by 109
Ng, C. Y., Yeh, Y.-T., Wang, C., Chung, W., Yang, C.-H., Chang, Y., Chang, W., Lin, Y., Chang, C., Su, S., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.02.808 · Cited by 108
Huppertz, A., Hermann, K., Diekhoff, T., Wagner, M., Hamm, B., & Schmidt, W. (2014) · Rheumatology International · doi:10.1007/s00296-014-2979-1 · Cited by 105
Kim, S. C., Newcomb, C. W., Margolis, D. J., Roy, J., & Hennessy, S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21817 · Cited by 102
Validation of a radiographic damage index in chronic gout
Dalbeth, N., Clark, B., McQueen, F. M., Doyle, A., & Taylor, W. J. (2007) · Arthritis Care & Research · doi:10.1002/art.22891 · Cited by 94
MacDonald, T. M., Ford, I., Nuki, G., Mackenzie, I. S., De Caterina, R., Findlay, E., Hallas, J., Hawkey, C. J., Ralston, S., Walters, M., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005354 · Cited by 93
Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.
Richette, P., Brière, C., Hoenen-Clavert, V., Lœuille, D., & Bardin, T. (2007) · PubMed · Cited by 91
Self-citationABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout
Roberts, R. L., Wallace, M. C., Phipps‐Green, A. J., Topless, R., Drake, J. M., Tan, P. C. S., Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.101 · Cited by 90
Oral Prednisolone in the Treatment of Acute Gout
Rainer, T. H., Cheng, C. H., Janssens, H., Man, C. Y., Tam, L., Choi, Y. F., Yau, W. H., Lee, K. H., & Graham, C. A. (2016) · Annals of Internal Medicine · doi:10.7326/m14-2070 · Cited by 90
Allopurinol and mortality in hyperuricaemic patients
Luk, A. J., Levin, G. P., Moore, E. E., Zhou, X., Kestenbaum, B. R., & Choi, H. K. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep069 · Cited by 88
Imaging in gout - What can we learn from MRI, CT, DECT and US?
McQueen, F. M., Doyle, A., & Dalbeth, N. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3489 · Cited by 88
The association of vitamin C, alcohol, coffee, tea, milk and yogurt with uric acid and gout
Towiwat, P., & Li, Z. (2015) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12622 · Cited by 87
Treatment adherence in patients with gout
Reach, G. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.05.010 · Cited by 84
Pui, K., Gow, P. J., & Dalbeth, N. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121301 · Cited by 82
Adherence to the Mediterranean diet and serum uric acid: the ATTICA study
Kontogianni, M. D., Chrysohoou, C. A., Panagiotakos, D., Tsetsekou, E., Zeimbekis, A., Pitsavos, C. E., & Stefanadis, C. (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2012.679964 · Cited by 80
Latest evidence on gout management: what the clinician needs to know
Burns, C. M., & Wortmann, R. L. (2012) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622312462056 · Cited by 79
Mechanisms of Spontaneous Resolution of Acute Gouty Inflammation
Steiger, S., & Harper, J. L. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0392-5 · Cited by 74
Imaging in gout: A review of the recent developments
Chowalloor, P., Siew, T., & Keen, H. I. (2014) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x14542960 · Cited by 73
Mechanism of high affinity inhibition of the human urate transporter URAT1
Tan, P. K., Ostertag, T. M., & Miner, J. N. (2016) · Scientific Reports · doi:10.1038/srep34995 · Cited by 72
Bardin, T., Chalès, G., Pascart, T., Flipo, R.-M., Ea, H., Roujeau, J., Delayen, A., & Clerson, P. (2015) · Joint Bone Spine · doi:10.1016/j.jbspin.2015.07.011 · Cited by 68
Self-citationComputed tomography measurement of tophus volume: Comparison with physical measurement
Dalbeth, N., Clark, B., Gregory, K., Gamble, G. D., Doyle, A., & McQueen, F. M. (2007) · Arthritis Care & Research · doi:10.1002/art.22612 · Cited by 66
Prophylaxis for acute gout flares after initiation of urate-lowering therapy
Latourte, A., Bardin, T., & Richette, P. (2014) · Rheumatology · doi:10.1093/rheumatology/keu157 · Cited by 65
Self-citationThe advanced imaging of gouty tophi
Gentili, A. (2006) · Current Rheumatology Reports · doi:10.1007/s11926-996-0030-6 · Cited by 62
Predicting allopurinol response in patients with gout
Wright, D. F. B., Duffull, S. B., Merriman, T. R., Dalbeth, N., Barclay, M. L., & Stamp, L. K. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12799 · Cited by 62
An update on the pathology and clinical management of gouty arthritis
González, E. B. (2011) · Clinical Rheumatology · doi:10.1007/s10067-011-1877-0 · Cited by 56
Challenges Faced by Patients in Gout Treatment
Singh, J. A. (2014) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000091 · Cited by 56
Allopurinol-Induced Interstitial Nephritis
Gelbart, D., WEINSTEIN, A. B., & FAJARDO, L. F. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-2-196 · Cited by 53
The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis)
Busso, N., & Ea, H. (2012) · Reumatismo · doi:10.4081/reumatismo.2011.230 · Cited by 53
Juge, P., Truchetet, M., Pillebout, É., Ottaviani, S., Vigneau, C. M., Loustau, C., Cornec, D., Pascart, T., Snanoudj, R., Bailly, F., et al. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.09.020 · Cited by 53
Self-citationPascual, E., Tovar, J. C., & Ruiz, M. T. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.12.983 · Cited by 52
ACTH as first line treatment for acute gout in 181 hospitalized patients
Daoussis, D., Antonopoulos, I., Yiannopoulos, G., & Andonopoulos, A. P. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.09.009 · Cited by 43
Review: Gout: A Roadmap to Approaches for Improving Global Outcomes
Dalbeth, N., Choi, H. K., & Terkeltaub, R. A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39799 · Cited by 38
Gout and Osteoarthritis: Associations, Pathophysiology, and Therapeutic Implications
Yokose, C., Chen, M., Berhanu, A., Pillinger, M. H., & Krasnokutsky, S. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0613-9 · Cited by 37
Reginato, A. M., & Olsen, B. R. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328040c00b · Cited by 34
Omoumi, P., Verdun, F. R., & Becce, F. (2015) · Seminars in Musculoskeletal Radiology · doi:10.1055/s-0035-1569254 · Cited by 25
Imaging as a potential outcome measure in gout studies: A systematic literature review
Durcan, L., Grainger, R., Keen, H. I., Taylor, W. J., & Dalbeth, N. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.09.008 · Cited by 24
Boonmuang, P., Nathisuwan, S., Chaiyakunapruk, N., Suwankesawong, W., Pokhagul, P., Teerawattanapong, N., & Supsongserm, P. (2013) · Drug Safety · doi:10.1007/s40264-013-0055-5 · Cited by 24
Physiopathologie de l’inflammation goutteuse
Ea, H. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2011.03.016 · Cited by 23
Ott, J. G., Racine, D., Omoumi, P., Becce, F., & Verdun, F. R. (2015) · Seminars in Musculoskeletal Radiology · doi:10.1055/s-0035-1569255 · Cited by 18
Gout Initially Mimicking Rheumatoid Arthritis and Later Cervical Spine Involvement
Nunes, E. A. S., Rosseti, A. G., Ribeiro, D. S., & Santiago, M. B. (2014) · Case Reports in Rheumatology · doi:10.1155/2014/357826 · Cited by 17
Cited by
Inflammation in gout: mechanisms and therapeutic targets
So, A. K., & Martinon, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.155 · Cited by 608
From purines to purinergic signalling: molecular functions and human diseases
Huang, Z., Xie, N., Illes, P., Di Virgilio, F., Ulrich, H., Semyanov, A., Verkhratsky, A., Sperlagh, B., Yu, S.-G., Huang, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00553-z · Cited by 489
Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation
Marinho, A., Nunes, C., & Reis, S. (2021) · Biomolecules · doi:10.3390/biom11101518 · Cited by 460
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312
Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
Cabău, G., Crișan, T. O., Klück, V., Popp, R. A., & Joosten, L. A. B. (2020) · Immunological Reviews · doi:10.1111/imr.12833 · Cited by 261
Metadata
- Authors
- Ragab, G., Elshahaly, M., & Bardin, T.
- Venue
- Journal of Advanced Research
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 8
- Issue
- 5
- Pages
- 495-511
- ISSN
- 2090-1224 (ISSN-L)
- 2090-1232
- OpenAlex
- W2613828117
- Cited by
- 599
- References
- 125
- FWCI
- 28.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.